Enzymotec Ltd. Reports Third Quarter 2016 Unaudited Financial Results
16 nov. 2016 07h30 HE
|
Enzymotec Ltd.
Nutrition Segment increased Adjusted EBITDA* to $4M, representing 27% year-over-year and 17% sequential growth VAYA Pharma sales to patients grew 45% year-over-year, but inventory destocking by...
Enzymotec Ltd. Announces Departure of its CEO
16 nov. 2016 07h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Nov. 16, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid based...
Enzymotec to Report Third Quarter 2016 Financial Results
02 nov. 2016 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
Enzymotec Ltd. Granted New Patents for INFAT® in the U.S., Vayacog® in Japan and Phospholipid-Based Products in Canada and Korea
27 sept. 2016 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Sept. 27, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid...
Enzymotec Ltd. Reports Second Quarter 2016 Unaudited Financial Results
09 août 2016 07h30 HE
|
Enzymotec Ltd.
VAYA Pharma Generated Record Net Revenues of $3.4 Million GAAP Diluted EPS Impacted by Decline in the Krill Oil Revenues Two U.S. Based Multinationals and...
Enzymotec Ltd. To Present at Two Upcoming Investor Conferences
02 août 2016 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and...
Enzymotec to Report Second Quarter 2016 Financial Results
26 juil. 2016 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 26, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and...
CORRECTING and REPLACING -- Enzymotec Ltd. Calls its 2016 Annual General Meeting of Shareholders
13 juil. 2016 17h00 HE
|
Enzymotec Ltd.
In the news release, Enzymotec Ltd. Calls its 2016 Annual General Meeting of Shareholders, issued July 13, 2016 by Enzymotec Ltd., we are advised by the company of the following amendments to the...
Enzymotec Ltd. Calls for its 2016 Annual General Meeting of Shareholders
13 juil. 2016 08h30 HE
|
Enzymotec Ltd.
MIGDAL HA’EMEQ, Israel, July 13, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY) (the “Company”), today announced that it will hold its 2016 Annual General Meeting of Shareholders (the...
Enzymotec Ltd. Reports First Quarter 2016 Unaudited Financial Results
19 mai 2016 07h30 HE
|
Enzymotec Ltd.
Reports Net Revenues of $14.0 Million, Earns $0.09 Per Diluted Share (non-GAAP) and Generates $3.3 Million in Operating Cash Flow VAYA Pharma Generates Record Net Revenues of $3.1 Million ...